LINKER-MM1 Update
LINKER-MM1 Update: Phase I/II Trial of Anti-BCMAxCD3 Bispecific Antibody Linvoseltamab in Relapsed/Refractory Multiple Myeloma

Released: December 14, 2023

Activity

Progress
1
Course Completed